{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:00:47Z","timestamp":1763017247654},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s11883-012-0296-2","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T07:11:40Z","timestamp":1355209900000},"source":"Crossref","is-referenced-by-count":11,"title":["The Rationale for Initiating Treatment of Hypercholesterolemia in Young Adulthood"],"prefix":"10.1007","volume":"15","author":[{"given":"Daniel","family":"Steinberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"296_CR1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jama.1953.03690120006002","volume":"152","author":"WF Enos","year":"1953","unstructured":"Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc. 1953;152:1090\u20133.","journal-title":"J Am Med Assoc"},{"key":"296_CR2","doi-asserted-by":"crossref","unstructured":"McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 1998;82:30T-6T.","DOI":"10.1016\/S0002-9149(98)00720-6"},{"key":"296_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1440-1827.1995.tb03476.x","volume":"45","author":"JP Strong","year":"1995","unstructured":"Strong JP, Malcom GT, Oalmann MC. Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathobiological Determinants of Atherosclerosis in Youth. Pathol Int. 1995;45:403\u20138.","journal-title":"Pathol Int"},{"key":"296_CR4","unstructured":"Berenson GS, Srinivasan SR, Bao W, Newman WP, III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk"},{"key":"296_CR5","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","volume":"103","author":"EM Tuzcu","year":"2001","unstructured":"Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation. 2001;103:2705\u201310.","journal-title":"Circulation"},{"key":"296_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/clinchem\/41.1.134","volume":"41","author":"JP Strong","year":"1995","unstructured":"Strong JP. Natural history and risk factors for early human atherogenesis. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Clin Chem. 1995;41:134\u20138.","journal-title":"Clin Chem"},{"key":"296_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","volume":"113","author":"DM Lloyd-Jones","year":"2006","unstructured":"Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50\u00a0years of age. Circulation. 2006;113:791\u20138.","journal-title":"Circulation"},{"key":"296_CR8","unstructured":"Constantinides P. Experimental atherosclerosis. Amsterdam: Elsevier, 1965:1."},{"key":"296_CR9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.ATV.14.5.840","volume":"14","author":"HC Stary","year":"1994","unstructured":"Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994;14:840\u201356.","journal-title":"Arterioscler Thromb"},{"key":"296_CR10","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1001\/jama.290.17.2320","volume":"290","author":"HC McGill Jr","year":"2003","unstructured":"McGill Jr HC, McMahan CA. Starting earlier to prevent heart disease. JAMA. 2003;290:2320\u20132.","journal-title":"JAMA"},{"key":"296_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","volume":"94","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wilson PW, Larson MG, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20\u20134.","journal-title":"Am J Cardiol"},{"key":"296_CR12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.1125884","volume":"311","author":"MS Brown","year":"2006","unstructured":"Brown MS, Goldstein JL. Biomedicine. Lowering LDL\u2013not only how low, but how long? Science. 2006;311:1721\u20133.","journal-title":"Science"},{"key":"296_CR13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/CIRCULATIONAHA.107.753152","volume":"118","author":"D Steinberg","year":"2008","unstructured":"Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation. 2008;118:672\u20137. This article summarizes the case for earlier intervention based on the natural history of atherogenesis and the newer genetic evidence.","journal-title":"Circulation"},{"key":"296_CR14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrcardio.2011.158","volume":"8","author":"M Domanski","year":"2011","unstructured":"\u2022 Domanski M, Lloyd-Jones D, Fuster V, Grundy S. Can we dramatically reduce the incidence of coronary heart disease? Nat Rev Cardiol. 2011;8:721\u20135. This article reviews the evidence supporting earlier intervention and proposes a large, formal RTC to evaluate the benefits.","journal-title":"Nat Rev Cardiol"},{"key":"296_CR15","doi-asserted-by":"crossref","unstructured":"The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365\u201374.","DOI":"10.1001\/jama.1984.03340270043026"},{"key":"296_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:11\u20137. This article demonstrates the safety and effectiveness of statin treatment even in those at relatively low risk.","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"296_CR17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley Jr TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264\u201372.","journal-title":"N Engl J Med"},{"key":"296_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34:154\u20136.","journal-title":"Nat Genet"},{"key":"296_CR19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(07)60516-9","volume":"369","author":"R McPherson","year":"2007","unstructured":"McPherson R, Kavaslar N. Statins for primary prevention of coronary artery disease. Lancet. 2007;369:1078.","journal-title":"Lancet"},{"key":"296_CR20","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1056\/NEJMc0707445","volume":"358","author":"S Kathiresan","year":"2008","unstructured":"Kathiresan S. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N Engl J Med. 2008;358:2299\u2013300.","journal-title":"N Engl J Med"},{"key":"296_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","volume":"40","author":"CJ Willer","year":"2008","unstructured":"Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161\u20139.","journal-title":"Nat Genet"},{"key":"296_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","volume":"40","author":"S Kathiresan","year":"2008","unstructured":"Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189\u201397.","journal-title":"Nat Genet"},{"key":"296_CR23","unstructured":"\u2022 Ference B, Yoo W, Alesh I, et al. A Mendelian randomized study of long term reduction of low-density lipoprotein cholesterol. J Am Coll Cardiol, in press. This article presents a meta-analysis of published data on mutations affecting LDL levels and the magnitude of the resultant reduction in lifetime risk."},{"key":"296_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34\u201347.","journal-title":"Science"},{"key":"296_CR25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0305-0491(71)90234-3","volume":"40","author":"GL Mills","year":"1971","unstructured":"Mills GL, Taylaur CE. The distribution and composition of serum lipoproteins in eighteen animals. Comp Biochem Physiol B. 1971;40:489\u2013501.","journal-title":"Comp Biochem Physiol B"},{"key":"296_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1172\/JCI109451","volume":"64","author":"D Steinberg","year":"1979","unstructured":"Steinberg D, Grundy SM, Mok HY, et al. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypoalphalipoproteinemia and fasting chylomicronemia. J Clin Invest. 1979;64:292\u2013301.","journal-title":"J Clin Invest"},{"key":"296_CR27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267\u201378.","journal-title":"Lancet"},{"key":"296_CR28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E. Fonseco FAHea. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195\u2013207.","journal-title":"N Engl J Med"},{"key":"296_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","volume":"292","author":"A Wiegman","year":"2004","unstructured":"Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331\u20137.","journal-title":"JAMA"},{"key":"296_CR30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","volume":"116","author":"J Rodenburg","year":"2007","unstructured":"Rodenburg J, Vissers MN, Wiegman A, et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007;116:664\u20138.","journal-title":"Circulation"},{"key":"296_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","volume":"357","author":"NJ Samani","year":"2007","unstructured":"Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443\u201353.","journal-title":"N Engl J Med"},{"key":"296_CR32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2009.12.057","volume":"56","author":"D Steinberg","year":"2010","unstructured":"\u2022 Steinberg D. Earlier intervention in the management of hypercholesterolemia: what are we waiting for? J Am Coll Cardiol. 2010;56:627\u20139. This article presents arguments for recommending earlier intervention without waiting for RCT data.","journal-title":"J Am Coll Cardiol"},{"key":"296_CR33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MOL.0b013e3280108740","volume":"17","author":"DM Lloyd-Jones","year":"2006","unstructured":"Lloyd-Jones DM. Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines. Curr Opin Lipidol. 2006;17:619\u201325.","journal-title":"Curr Opin Lipidol"},{"key":"296_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.0000154544.90488.52","volume":"111","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cook N. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. Circulation. 2005;111:657\u20138.","journal-title":"Circulation"},{"key":"296_CR35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jacc.2008.06.036","volume":"52","author":"D Steinberg","year":"2008","unstructured":"Steinberg D. Statin treatment does not cause cancer. J Am Coll Cardiol. 2008;52:1148\u20139.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-012-0296-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-012-0296-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-012-0296-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T12:40:32Z","timestamp":1595076032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-012-0296-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1007\/s11883-012-0296-2","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]},"article-number":"296"}}